Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61,024 | -$2,735 | -$379 | -$174 |
| Dep. & Amort. | $308 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $10,615 | $0 | $0 | $0 |
| Change in WC | $0 | $1,156 | $122 | $2,044 |
| Other Non-Cash | -$457 | $0 | -$16 | -$2,129 |
| Operating Cash Flow | -$50,558 | -$1,579 | -$272 | -$259 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$289 | $0 | $0 | $0 |
| Net Acquisitions | -$602 | $0 | $0 | $0 |
| Inv. Purchases | -$72,648 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $86,628 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $92,591 | $0 | -$160,000 |
| Investing Cash Flow | $13,089 | $92,591 | $0 | -$160,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $352 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $29,171 | -$92,591 | $0 | $162,285 |
| Financing Cash Flow | $29,171 | -$92,591 | $0 | $162,285 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,298 | -$1,579 | -$272 | $2,027 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,559 | $1,754 | $2,027 | $0 |
| End Cash | $22,261 | $175 | $1,754 | $2,027 |
| Free Cash Flow | -$50,847 | -$1,579 | -$272 | -$259 |